FAMI.NASDAQFarmmi, INC

20-F: Farmmi Inc. Reports Fiscal Year 2024 Results: Revenue Declines Amidst Strategic Shifts

Sentiment:

Annual Results


Farmmi Inc.'s fiscal year 2024 saw a significant revenue decrease, driven by strategic shifts and market dynamics, as detailed in its latest 20-F filing.

Worse than expectedThe company's revenue decreased by 41.9% year-over-year.The company experienced a net loss of $4.6 million, compared to a net income of $2.5 million in the previous year.Gross profit declined by 9.6%.

Summary

  • Farmmi Inc., a Cayman Islands holding company, conducts its operations primarily in China through its subsidiaries.
  • The company's revenue for fiscal year 2024 decreased by 41.9% to $64.1 million, compared to $110.4 million in fiscal year 2023.
  • This decline is attributed to strategic shifts in product focus and changes in market demand.
  • The company reported a net loss of $4.6 million for fiscal year 2024, a significant change from the $2.5 million net income in fiscal year 2023.
  • The company's gross profit also decreased by 9.6% to $3.9 million in fiscal year 2024.
  • The company divested several subsidiaries, including Zhejiang Farmmi Holdings Group Co., Ltd, Farmmi (Hangzhou) Ecology Agriculture Development Co., Ltd, and Lishui Farmmi Technology Co., Ltd to streamline operations.
  • The company's strategic focus is shifting towards high-quality agricultural products and expanding its international market presence.
  • The company is subject to various risks, including those related to doing business in China, industry-specific challenges, and ownership of ordinary shares.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While there are some positive aspects, such as the company's focus on high-quality products and international expansion, the significant decline in revenue and net income, coupled with internal control weaknesses, contribute to a negative sentiment.

Positives

  • The company is focusing on high-quality agricultural products, which may lead to increased demand and higher profit margins.
  • The company is expanding its international market presence, which could diversify its revenue streams and reduce reliance on the Chinese market.
  • The company has implemented a food quality traceability system to ensure product quality and safety.
  • The company has a policy restricting third party guarantees.
  • The company has a compensation clawback policy in place.

Negatives

  • The company experienced a significant decrease in revenue and a shift from net income to a net loss.
  • The company is heavily reliant on a single major customer, which poses a risk to its revenue stream.
  • The company faces risks related to doing business in China, including government intervention and regulatory uncertainties.
  • The company's internal control over financial reporting was deemed ineffective as of September 30, 2024.
  • The company's shares may be delisted if it fails to comply with Nasdaq continued listing requirements.

Risks

  • The PRC government may intervene in or influence the company's operations.
  • Uncertainties in the interpretation and enforcement of PRC laws and regulations could limit legal protections.
  • Trading in the company's securities may be prohibited under the Holding Foreign Companies Accountable Act if the PCAOB cannot inspect the company's auditors.
  • The loss of any key customers could reduce revenues and profitability.
  • The company buys its supplies from a relatively limited number of suppliers.
  • The company faces risks related to health epidemics that could impact sales and operating results.
  • The edible fungi cultivated by the company's suppliers is subject to risks related to diseases, pests, abnormal temperature change and extreme weather events.
  • The market price of the company's ordinary shares may be volatile or may decline regardless of operating performance.
  • The company may be exposed to liabilities under the Foreign Corrupt Practices Act and Chinese anti-corruption law.

Future Outlook

The company expects its sales of edible fungi products to grow in the coming years, driven by increasing consumption in China and international markets. The company plans to expand its product lines, improve brand awareness, and enhance customer loyalty.

Industry Context

The global mushroom market is expected to reach USD 100.31 billion by 2032, growing at a CAGR of 8%. China is the largest worldwide edible mushroom producer, but consumption per capita is lower than in other countries, indicating potential for growth.

Comparison to Industry Standards

  • The document mentions competitors such as Zhejiang Jingning Nature Food Co. Ltd and Zhejiang Tianhe Food Co., Ltd, both based in Lishui, China.
  • These companies are also involved in the processing and sales of edible fungi products.
  • However, the document does not provide specific financial comparisons to these companies or other industry benchmarks.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorZhengyu WangChenyang WangJanuary 2025Resignation

Related Party Transactions

  • The company has related party transactions with Zhejiang Yili Yuncang Technology Group Co., Ltd, FarmNet Limited, Epakia Canada Inc, Forasen Group Co., Ltd, Zhang Bin, Shanghai Zhongjian Yiting Medical Health Technology Partnership, Zhang Dehong, Yefang Zhang, Zhejiang Tantech Bamboo Technology Co., Ltd, and Forasen Holdings Group Co., Ltd.
  • These transactions include sales, lease agreements, and expense payments.

Stakeholder Impact

  • Shareholders may be concerned about the decline in revenue and net income, as well as the ineffective internal control over financial reporting.
  • Employees may be affected by the company's strategic shifts and cost-cutting measures.
  • Customers may be impacted by changes in product offerings and pricing.
  • Suppliers may be affected by changes in the company's procurement practices.

Next Steps

  • The company intends to continue to carefully execute its growth plans and manage market risk.
  • The company plans to hire experts to improve and test its internal control and the set up a series of standard and recurring internal audit work procedures before September 2025.
  • The company schedule to perform self-assessment of internal control effectiveness on a continuous basis, which will be led by our accounting and risk management department within fiscal year 2025.
  • The company also plan to hire more competent personnel and involve professional service companies to help us implement SOX 404 compliance together with the establishment of our internal audit function.

Key Dates

DateDescription
2011-03-31Establishment of Zhejiang FLS Mushroom Co., Ltd
2015-07-28Farmmi, Inc. was incorporated in the Cayman Islands
2018-02-16FAMI completed its initial public offering and its Ordinary Shares commenced trading on Nasdaq
2021-09-27Acquisition of Jiangxi Xiangbo Agriculture and Forestry Development Co. Ltd
2022-09-26Company entered into a securities purchase agreement with Streeterville Capital, LLC
2023-03-31Trial Measures for the Administration of Overseas Issuance and Listing of Securities by Domestic Enterprises took effect
2024-01-31Zhejiang Suyuan Agricultural Technology Co., Ltd sold 100% of the equity of its wholly owned subsidiary, Zhejiang Farmmi Holdings Group Co., Ltd
2024-07-30Company entered into a note purchase agreement with Atlas Sciences, LLC
2024-08-22Company and certain institutional investors entered into a securities purchase agreement
2024-09-18Farmmi International Limited sold 100% of the equity of its wholly owned subsidiary, Farmmi (Hangzhou) Ecology Agriculture Development Co., Ltd
2024-09-23Farmmi International Limited sold 100% of the equity of its wholly owned subsidiary, Lishui Farmmi Technology Co., Ltd
2024-09-30End of fiscal year 2024

Keywords

Farmmi, financial results, agricultural products, revenue, net income, China, risk factors, internal control, PCAOB, securities, mushrooms

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.